Rb-/-Rbl2-/- ESCs developed a teratoma in 4 out of 6 mice; in contrast, Rb-/-Rbl2-/-p53-/- ESCs developed a tumor in 6 out of 6 injected mice. This evidence concerns the gene TP53 and neoplasm.